help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 26, 2007
Endocrinology, doi:10.1210/en.2007-0312
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/2/461    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salani, B.
Right arrow Articles by Maggi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salani, B.
Right arrow Articles by Maggi, D.

Submitted on March 7, 2007
Accepted on November 9, 2007

Caveolin-1 down regulation inhibits IGF-IR signal transduction in H9C2 rat cardio myoblasts

Barbara Salani, Lucia Briatore, Silvano Garibaldi, Renzo Cordera, and Davide Maggi*

Department of Endocrinology and Medicine, and Department of Internal Medicine, University of Genova, Genova, Italy

* To whom correspondence should be addressed. E-mail: davide.maggi{at}unige.it.

Caveolin-1, the major caveolar protein, directly interacts with IGF-I Receptor (IGF-IR) and its intracellular substrates. To determine the role of caveolin-1 in IGF-IR signaling, we transfected H9C2 cells with small interfering RNA specific for caveolin-1 (Cav-1-siRNA). The selective down regulation of caveolin-1 (90%) was associated with a smaller reduction of caveolin-2 while caveolin-3 expression was unaffected. A significant reduction of IGF-IR tyrosine phosphorylation in Cav-1-siRNA H9C2 cells was found compared to H9C2 control cells (Ctr-siRNA). The reduced IGF-IR auto phosphorylation resulted in a decrease of IRS-1, Shc and Akt activation. In addition, in Cav-1-siRNA H9C2 cells IGF-I did not prevented apoptosis, suggesting that caveolin-1 is required to mediate the anti-apoptotic effect of IGF-I in cardio myoblasts. The down regulation of caveolin-1 decreased IGF-IR activation and affected the ability of IGF-I to prevent apoptosis after serum withdrawal also in human umbilical vein endothelial cells (HUVECs). These results demonstrate that: 1) caveolin-1 down regulation negatively affects IGF-IR tyrosine phosphorylation; 2) this effect causes a reduced activation of IRS-1, Shc, Akt; 3) caveolin-1 is involved in IGF-IR antiapoptotic signaling following serum deprivation.


Key words: caveolin-1 • caveolin-3 • IGF-IR • IRS 1 • Shc • cardio myoblasts







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society